1887

Abstract

Human cells do not normally support productive bovine adenovirus type 3 (BAdV-3) infection. Here, the outcome of BAdV-3 infection of both 293 cells and 293 cells modified to constitutively express the simian virus 40 (SV-40) T antigen (293T cells) was studied. Whereas BAdV-3 could efficiently infect 293 cells, there was a block in virus DNA replication, late-gene expression and virus production. In contrast, replication and efficient virus production could be detected in 293T cells infected with BAdV-3 or transfected with a replication-competent genomic BAdV-3 clone (pFBAV304). Early-phase gene expression was detected readily in both BAdV-3-infected 293 and 293T cells. However, the progression to efficient viral DNA synthesis and late-phase protein synthesis occurred only in 293T cells. Electron microscopy and virus growth kinetics demonstrated the formation of progeny virus in 293T cells. The SV-40 T antigens act to overcome a barrier in BAdV-3 DNA replication in 293 cells.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.81305-0
2006-04-01
2024-12-09
Loading full text...

Full text loading...

/deliver/fulltext/jgv/87/4/817.html?itemId=/content/journal/jgv/10.1099/vir.0.81305-0&mimeType=html&fmt=ahah

References

  1. Bangari D. S., Shukla S., Mittal S. K. 2005; Comparative transduction efficiencies of human and nonhuman adenoviral vectors in human, murine, bovine, and porcine cells in culture. Biochem Biophys Res Commun 327:960–966 [CrossRef]
    [Google Scholar]
  2. DuBridge R. B., Tang P., Hsia H. C., Leong P.-M., Miller J. H., Calos M. P. 1987; Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 7:379–387
    [Google Scholar]
  3. Eron L., Westphal H., Khoury G. 1975; Post-transcriptional restriction of human adenovirus expression in monkey cells. J Virol 15:1256–1261
    [Google Scholar]
  4. Graham F. L., Smiley J., Russell W. C., Nairn R. 1977; Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59–72 [CrossRef]
    [Google Scholar]
  5. Hosel M., Webb D., Schroer J., Doerfler W. 2003; The abortive infection of Syrian hamster cells with human adenovirus type 12. Curr Top Microbiol Immunol 272:415–440
    [Google Scholar]
  6. Imler J.-L. 1995; Adenovirus vectors as recombinant viral vaccines. Vaccine 13:1143–1151 [CrossRef]
    [Google Scholar]
  7. Klonjkowski B., Gillardi-Hebenstreit P., Hadchouel J., Randrianarison V., Boutin S., Yeh P., Perricaudet M., Kremer E. J. 1997; A recombinant E1-deleted canine adenoviral vector capable of transduction and expression of a transgene in human-derived cells and in vivo. Hum Gene Ther 8:2103–2115 [CrossRef]
    [Google Scholar]
  8. Kulshreshtha V., Babiuk L. A., Tikoo S. K. 2004; Role of bovine adenovirus-3 33K protein in viral replication. Virology 323:59–69 [CrossRef]
    [Google Scholar]
  9. Kümin D., Hofmann C., Rudolph M., Both G. W., Löser P. 2002; Biology of ovine adenovirus infection of nonpermissive cells. J Virol 76:10882–10893 [CrossRef]
    [Google Scholar]
  10. Loeken M. R. 1992; Simian virus 40 small t antigen trans activates the adenovirus E2A promoter by using mechanisms distinct from those used by adenovirus E1A. J Virol 66:2551–2555
    [Google Scholar]
  11. Nicolas J. C., Sarnow P., Girard M., Levine A. J. 1983; Host range temperature-conditional mutants in the adenovirus DNA binding protein are defective in the assembly of infectious virus. Virology 126:228–239 [CrossRef]
    [Google Scholar]
  12. Pieniazek D., Pieniazek N. J., Macejak D., Coward J., Rayfield M., Luftig R. B. 1990; Differential growth of human enteric adenovirus 41 (TAK) in continuous cell lines. Virology 174:239–249 [CrossRef]
    [Google Scholar]
  13. Rasmussen U. B., Benchaibi M., Meyer V., Schlesinger Y., Schughart K. 1999; Novel human gene transfer vectors: evaluation of wild-type and recombinant animal adenoviruses in human-derived cells. Hum Gene Ther 10:2587–2599 [CrossRef]
    [Google Scholar]
  14. Reddy P. S., Idamakanti N., Zakhartchouk A. N., Baxi M. K., Lee J. B., Pyne C., Babiuk L. A., Tikoo S. K. 1998; Nucleotide sequence, genome organization, and transcription map of bovine adenovirus type 3. J Virol 72:1394–1402
    [Google Scholar]
  15. Reddy P. S., Idamakanti N., Chen Y., Whale T., Babiuk L. A., Mehtali M., Tikoo S. K. 1999; Replication-defective bovine adenovirus type 3 as an expression vector. J Virol 73:9137–9144
    [Google Scholar]
  16. Ross D., Ziff E. 1994; Defective processing of human adenovirus 2 late transcription unit mRNAs during abortive infections in monkey cells. Virology 202:107–115 [CrossRef]
    [Google Scholar]
  17. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: a Laboratory Manual , 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
  18. Silverman L., Klessig D. F. 1989; Characterization of the translational defect to fiber synthesis in monkey cells abortively infected with human adenovirus: role of ancillary leaders. J Virol 63:4376–4385
    [Google Scholar]
  19. Sullivan C. S., Pipas J. M. 2002; T antigens of simian virus 40: molecular chaperones for viral replication and tumorigenesis. Microbiol Mol Biol Rev 66:179–202 [CrossRef]
    [Google Scholar]
  20. van Breukelen B., Brenkman A. B., Holthuizen P. E., van der Vliet P. C. 2003; Adenovirus type 5 DNA binding protein stimulates binding of DNA polymerase to the replication origin. J Virol 77:915–922 [CrossRef]
    [Google Scholar]
  21. Wu Q., Tikoo S. K. 2004; Altered tropism of recombinant bovine adenovirus type-3 expressing chimeric fiber. Virus Res 99:9–15 [CrossRef]
    [Google Scholar]
  22. Xu Z. Z., Hyatt A., Boyle D. B., Both G. W. 1997; Construction of ovine adenovirus recombinants by gene insertion or deletion of related terminal region sequences. Virology 230:62–71 [CrossRef]
    [Google Scholar]
  23. Zhou Y., Pyne C., Tikoo S. K. 2001; Determination of bovine adenovirus-3 titer based on immunohistochemical detection of DNA binding protein in infected cells. J Virol Methods 94:147–153 [CrossRef]
    [Google Scholar]
/content/journal/jgv/10.1099/vir.0.81305-0
Loading
/content/journal/jgv/10.1099/vir.0.81305-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error